Today's Advertiser Page 60 "Stocks ripe for the picking 2020
ASX PAR. We are picking Paradigm for a third year in a row. after rising 275% in 2018 and 184% year to December 2017 The company continues to develop injectable Pentosan Polysulphate Sodium IPPS for treatment of osteoarthritis, a market measured in the billions of dollars.
key progress we expect this year includes beginning US Food and Drug Administration approved phase 3 trials. Due to the large numbers of people treated with IPPS under the Special Access Scheme in Australia, we expect rapid sales growth once approved!
The word is definitely spreading IMO
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-421
-
- There are more pages in this discussion • 3,897 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 34768 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 0.255 |
8 | 215150 | 0.250 |
6 | 109763 | 0.245 |
7 | 91034 | 0.240 |
2 | 54200 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 34768 | 1 |
0.270 | 500 | 1 |
0.275 | 6347 | 2 |
0.290 | 14580 | 3 |
0.295 | 10000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |